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Virus-encoded movement proteins (MPs) mediate cell-
to-cell spread of viral RNA through plant membranous
intercellular connections, the plasmodesmata. The mo-
lecular pathway by which MPs interact with viral ge-
nomes and target plasmodesmata channels is largely
unknown. The 9-kDa MP from carnation mottle carmo-
virus (CarMV) contains two potential transmembrane
domains. To explore the possibility that this protein is in
fact an intrinsic membrane protein, we have investi-
gated its insertion into the endoplasmic reticulum mem-
brane. By using in vitro translation in the presence of
dog pancreas microsomes, we demonstrate that CarMV
p9 inserts into the endoplasmic reticulum without the
aid of any additional viral or plant host components. We
further show that the membrane topology of CarMV p9
is Ncyt-Ccyt (N and C termini of the protein facing the
cytoplasm) by in vitro translation of a series of trun-
cated and full-length constructs with engineered glyco-
sylation sites. Based on these results, we propose a top-
ological model in which CarMV p9 is anchored in the
membrane with its N- and C-terminal tail segments in-
teracting with its soluble, RNA-bound partner CarMV
p7, to accomplish the viral cell-to-cell movement
function.
RNA is a structurally versatile molecule, and it performs
diverse biological roles in the cells. To fulfill these roles, RNA
almost invariably functions in association with proteins. This is
true also for RNA transport, where proteins stabilize, protect,
and target RNA for passage through the nucleocytoplasmic
pores or for intercellular trafficking. However, the functional
and structural analysis of the diverse families of RNA-binding
proteins is still far from completed.
One of these families of proteins whose mechanism of action
has not been fully characterized is the movement protein (MP)1
family found in plant viruses. The process of infection by plant
viruses depends on the cell-to-cell traffic of viruses within a
plant host. This process is mediated by MPs and is assumed to
take place through the plasmodesmata. These are membranous
channels that connect higher plant cells into a functional in-
tercellular communication network. Many proteins, including
several plant virus MPs (1), have been reported to be associated
with these specialized channels and to facilitate passage of a
variety of macromolecules into and between cells and cellular
compartments. Consequently, viral infection spreads through-
out the whole host plant (reviewed in Refs. 2–4). The spread of
infection is aided by interactions between pathogen and host
components (5). Furthermore, several MPs have been demon-
strated to increase plasmodesmatal size exclusion limits to
allow the movement of virus-nucleic acid complexes into adja-
cent cells (6, 7).
Although MPs are required for this dramatic and temporary
increase in intercellular permeability, the responsible mecha-
nism is so far unclear. However, because of the intrinsic mem-
branous composition of the plasmodesmata, it can be assumed
that many of the associated proteins could be membrane pro-
teins. Thus, the MP of the tobacco mosaic virus (TMV), a
member of the so-called 30-kDa superfamily of virus MPs (8, 9),
contains an integral membrane protein-like domain and a cy-
tosolically exposed RNA-binding domain (10). There is also
experimental evidence that supports a predominant role of
membrane protein-like domains in other MPs (11–13).
It has been reported that many plant viruses replicate in
association with the ER membrane, and in some cases it has
been postulated that membrane-integrated MPs would allow
the formation of the membrane-associated replication com-
plexes (14–16). MPs would thus contribute to the intracellular
distribution of the virus and to the above-mentioned manipu-
lation of plasmodesmal pores to facilitate cell-to-cell spread of
infection. Studies aimed at understanding the molecular basis
of multi-domain proteins often are confounded by the sheer
complexity of such proteins. Our goal is to uncover the dual
functions of MPs (RNA binding and membrane interaction)
through functional and structural analysis of MPs found in
viruses containing multiple single-domain MPs.
Carmoviruses are among the smallest known plant viruses
whose MPs do not belong to the multi-domain 30-kDa super-
family. Their genome is a positive sense single-stranded RNA
of 4 kb encoding at least five proteins (17, 18). The type
member of the group, carnation mottle carmovirus (CarMV),
has in the central region of the genome two small overlapping
open reading frames that code for two small MPs, p7 and p9. It
has been demonstrated in the closely related turnip crinkle
carmovirus that disruption of the homologous genes blocks the
cell-to-cell movement function of the virus (19).
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We have previously characterized CarMV p7 as a soluble
protein with RNA binding capacity (20) and have structurally
characterized, by means of a retrostructural approach, three
different protein domains of p7, including the RNA-binding
domain (21). Thus, comparing the MPs of Carmoviruses with
those of the 30-kDa superfamily (taking as representative TMV
MP), p7 should be considered as the equivalent to the cytoso-
lically exposed RNA-binding domain of TMV MP. Therefore,
CarMV p9 is a strong candidate for the membrane-embedded
domain found in TMV MP.
In the present study, we show that CarMV p9 is an integral
membrane protein. Sequence analysis of p9 and homologues
from related plant viruses shows two consensus hydrophobic
regions, suggesting the presence of two membrane-spanning
domains. Peptides corresponding to the two putative trans-
membrane segments of CarMV p9 have been analyzed by CD
spectroscopy, and the membrane inserting activity of the hy-
drophobic domains has been evaluated by in vitro transcrip-
tion/translation experiments using ER-derived dog pancreas
microsomes. In addition, we have used a glycosylation mapping
technique to determine the topology of CarMV p9 in the ER
membrane. A model is proposed where the RNA is targeted to
the membrane through an interaction between p7 and p9. Such
a protein complex would facilitate the cell-to-cell viral trans-
port through the plasmodesmata channels.
MATERIALS AND METHODS
Enzymes and Chemicals—Unless otherwise stated, all of the en-
zymes as well as plasmid pGEM1, RiboMAX SP6 RNA polymerase
system, and rabbit reticulocyte lysate were from Promega (Madison,
WI) or Roche Molecular Biochemicals. [35S]Met and 14C-methylated
marker proteins were from Amersham BioSciences. The PCR purifi-
cation and RNeasy RNA clean up kits were from Qiagen (Hilden,
Germany). The PCR mutagenesis kit QuikChange was from Stratagene
(La Jolla, CA). The oligonucleotides were from the Kebo Laboratory
(Stockholm, Sweden), Roche Molecular Biochemicals, and Isogen
(Maarssen, The Netherlands).
Peptide Synthesis and Purification—Peptides p93–24 and p936–57
were manually synthesized by solid phase peptide synthesis using
Fmoc (N-(9-fluorenyl)methoxycarbonyl) chemistry (39), and peptide
p956–84 was synthesized as a C-terminal carboxamide on a 0.10 mM
scale using an Applied Biosystems model 433A solid phase peptide
synthesizer. Analytical reversed-phase high pressure liquid chromatog-
raphy and laser desorption time-of-flight mass spectrometry were used
to determine the purity and identity of the peptides.
Circular Dichroism Spectroscopy—All of the measurements were
carried out on a Jasco J-810 CD spectropolarimeter in conjunction with
a Neslab RTE 110 water bath and temperature controller as in Ref. 21.
The secondary structure content was analyzed with the software pro-
vided with the spectropolarimeter, which uses as a reference the CD
spectra of model proteins (40).
Construction of Lep/p9 Fusions—p9 was cloned into pQE-9K from
viral RNA of infected Chenopodium quinoa plants by a reverse tran-
scription-PCR approach (23). Plasmids encoding Lep pGEM-Lep-NST
and pGEM-Lep-QST were previously generated (41). Introduction of
the hydrophobic fragments from the p9 protein into the Lep sequence
was carried out by replacing the H2 segment of Lep by PCR amplifica-
tion of pQE-9K with forward primers containing appropriate restriction
sites.
For the LepTM1 construct, residues 59–81 in H2 (see Fig. 2, top
panel) were replaced by residues 1–29 of p9; for LepTM2, again H2 was
replaced by residues 30–59 of p9; and for LepTM1TM2, H2 was also
replaced by residues 1–59 of p9. After PCR amplification, the PCR
products were purified, digested, and ligated to the corresponding Lep
vectors digested with the same enzymes. All of the constructs were
confirmed by DNA sequencing.
Construction of Full-length p9 and p9/P2 and p9TM1/P2 Fusions—
Cloning into pGEM1 was done using full-length p9 NcoI-NdeI frag-
ments from pQE-9K. To obtain full-length constructs, transcription of
p9 gene was done after PCR using a reverse primer carrying an stop
codon at the end of p9 sequence. Construct p9TM1/P2 was obtained by
PCR deletion of TM2 and the C terminus of p9.
In Vitro Mutagenesis—In constructs LepTM1TM2 and full-length p9,
the nucleotide sequence coding for Ala44-Leu45-Ser46 (numbering corre-
sponding to the p9 wild type sequence) roughly located in the middle of
the second TM fragment was changed to the sequence coding for Glu-
Glu-Glu, with the aim of obtaining a nontransmembrane segment as a
control for membrane insertion (see “Results”). In the full-length p9
constructs, the nucleotide sequence coding for the Asn-Tyr-Ser glycosy-
lation acceptor site at position 65–67 in the wild type protein was
changed to the nonacceptor Gln-Tyr-Ser, whereas an Asn-Ser-Ser was
introduced at codons 69–71 replacing the wild type Asp-Ser-Ser se-
quence (p9WT* construct), roughly 14 amino acids downstream of pu-
tative second TM fragment. For mutagenesis, the QuikChange kit was
used according to the manufacturer’s protocol from Stratagene. DNA
mutations were confirmed by DNA sequencing.
In Vitro Transcription and Translation in Reticulocyte Lysate—In
vitro transcription of Lep constructs was done as previously (24, 42).
The reactions were incubated at 37 °C for 2 h. The mRNAs were puri-
fied using a Qiagen RNeasy clean up kit and verified on a 1% agarose
gel.
In vitro translation of the mRNA synthesized from the in vitro
transcription was done in the presence of reticulocyte lysate and
[35S]Met. The Lep constructs were processed as described previously
(24, 42). For p9 constructs, after completion of the translation, the
samples were alkaline extracted (see below) and electrophoresed by
12% SDS-PAGE, and the assay was repeated in the presence either of
a glycosylation acceptor tripeptide Ac-Asn-Tyr-Thr-NH2 as described
(43) or of a nonacceptor tripeptide Ac-Gln-Tyr-Thr-NH2 (33 M in both
cases). For endoglycosidase H treatment, the translation mix was di-
luted (1:3) with 70 mM sodium citrate (pH 5.6) and ultracentrifugated
(100,000  g for 20 min) onto a sucrose cushion; pellet was redissolved
in 40 l of the same buffer with 0.5% SDS, 1% -mercaptoethanol and
boiled for 5 min; and the aliquots were then incubated at different times
with 0.1 milliunits of endoglycosidase H at 37 °C as described (30).
Alkaline Extraction of Microsomes—The alkaline flotation assays
were performed as described (44). For the alkaline extraction experi-
ments, 10 l of the in vitro translation mixture was added to 90 l of
100 mM Na2CO3 (pH 12.5) and incubated on ice for 20 min. This mixture
was layered onto a 50-l sucrose cushion and centrifuged at 100,000 
g for 10 min (Beckman TL 100 centrifuge). The pellet was resuspended
in 40 l of SDS-PAGE sample buffer and heated to 95 °C for 5 min while
shaking prior to analysis by SDS-PAGE. The supernatant was carefully
removed, acid-precipitated by the addition of trichloroacetic acid to
10%, and incubated at 4 °C for 10 min. The precipitate was pelleted by
centrifugation in a Microfuge, washed with acetone, dried, and similar
to above resuspended in SDS-PAGE sample buffer. All of the gels were
dried at 80 °C and scanned using a Fuji BAS1000 PhosphorImager
using the MacBAS 2.31 software.
RESULTS
Sequence Analysis of CarMV p9—Sequence comparisons of
p9 from CarMV and related plant viral homologues (Fig. 1A)
show two consensus hydrophobic regions linked by a polar loop,
suggesting the presence of two membrane-spanning (TM) do-
mains and a third highly charged region at the C terminus of
the protein. TM domain predictions generated by different
algorithms also identify two segments with high TM propen-
sity. As an example, Fig. 1B shows the probability of each
residue to be part of a TM fragment using the TMHMM 2.0
program (22), a method that uses a hidden Markov model for
predicting TM helices in protein sequences. The first putative
TM fragment extends from Asn5 to Leu23. Residues Arg24–
Ser32 define an extramembranous loop, whereas the second TM
fragment extends from Leu33 to Ile55. The polar C-terminal
domain (Ser56–Lys84) is predicted to form a water-soluble re-
gion. The loop connecting the two TM domains is rich in polar
residues (Ser and Thr) and also contains Pro residues. It is
noteworthy that in the more distantly related carmoviruses
galinsoga mosaic virus and melon necrotic spot virus (23), only
one TM segment is predicted (Fig. 1A), which is preceded by
polar and Pro residues, suggesting that a putative membrane-
anchoring function can be also fulfilled by just one membrane-
spanning motif. The same pattern is observed for the four
necroviruses sequenced to date (data not shown).
Retrostructural Analyses of CarMV p9—To individually an-
alyze the different p9 regions, we synthesized three different
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peptides. Two of them are derived from the putative TM
fragment domains (i.e. p93–24 and p936–57), and the third one
(p956–84) covers the C-terminal domain of the protein. CD anal-
ysis of these three peptides in the presence of the secondary
structure-inducing solvent trifluoroethanol indicated that pep-
tides p93–24 and p936–57 adopt an -helical conformation,
whereas p956–84 adopts a mixture of random coil and -sheet
conformation (data not shown). In the presence of the membrane-
mimetic detergent SDS at micellar concentrations, both p93–24
and p936–57 populate an -helical conformation (Fig. 1C), with a
higher helical content for p93–24 (60% -helix, 11% -sheet, 3%
turn, and 26% random) than for p936–57 (45% -helix, 19%
-sheet, 2% turn, and 34% random). As expected, the hydropho-
bic regions identified as putative TM fragments thus behave as
hydrophobic -helices when analyzed in detergent micelles. The
-sheet content in the p956–84 peptide that represents the hydro-
philic C-terminal region increases with the SDS concentration
from an estimated (see “Materials and Methods”) 60% -sheet
content in aqueous solution to 72% in the presence of 0.4 mM
SDS (Fig. 1D).
Insertion of the CarMV p9 -Helical TM Regions into Biolog-
ical Membranes—To examine the propensity of the two hydro-
phobic p9 segments to form TM helices in biological mem-
branes, an in vitro translation/translocation system with or
without added dog pancreas microsomes was used. The Esch-
erichia coli inner membrane protein Lep was used as an inser-
tion vehicle for the putative TM fragments. Lep is anchored in
the cytoplasmic membrane by two TM segments (H1 and H2)
that are connected by the P1 domain. The P2 domain forms the
C-terminal half of the protein (Fig. 2, top panel). Upon in vitro
transcription/translation in the presence of dog pancreas mi-
crosomes, Lep has been shown to insert into the microsomal
membrane with both the N and C termini on the luminal side
(24). An engineered glycosylation site placed downstream of H2
is glycosylated efficiently upon correct insertion into the micro-
somal membrane, serving as a reporter to distinguish between
a lumenal (glycosylated) and a cytoplasmic (unglycosylated)
location. Glycosylation of the molecule results in an increase in
molecular mass of about 2.5 kDa relative to the observed mo-
lecular mass of Lep expressed in the absence of microsomes.
The efficiency of glycosylation of Lep under standard conditions
is 80–90% (24–26). The microsomal in vitro system closely
mimics the conditions of in vivo membrane protein assembly
into the ER membrane.
To study the membrane insertion capacity of the predicted
TM fragments, the H2 segment of Lep (Fig. 2, top panel) was
replaced by the two hydrophobic p9 segments TM1 (residues
1–29, LepTM1) and TM2 (residues 30–59, LepTM2). A segment
with membrane insertion capacity will result in glycosylation
of the chimeras, whereas a segment that lacks membrane par-
FIG. 1. A, sequence alignment of CarMV-dix p9 and related open reading frames from eight carmoviruses. The synthetic peptides (see “Materials
and Methods”) are shown between arrowheads at the top. The consensus sequence is shown either as single-letter amino acid codes or as a 
symbol, which indicates Lys or Arg. Residues conserved in at least five of the nine sequences are shaded. Black boxes highlight A44E/L45E/S46E
triple mutation and the native glycosylation site at residue 65. SgCV, saguaro cactus virus; TCV, turnip crinkle virus; CCFV, cardamine chlorotic
fleck virus; HCRV, hibiscus chlorotic ringspot virus; JINRV, Japanese iris necrotic ring virus; CPMoV, cowpea mottle virus; GaMV, galinsoga
mosaic virus; MNSV, melon necrotic spot virus. B, TM probability plot for p9 using TMHMM 2.0 with default parameter settings (22). C, far UV
CD spectra of the putative TM fragments at 25 M in 5 mM MOPS/NaOH pH 7.0 buffer solution in the presence of 9 mM SDS. Solid line, peptide
p93–24; dotted line, peptide p936–57. D, SDS titration of the C terminus peptide at 50 M (in the same conditions as in C) in 0, 0.1, 0.2, and 0.4 mM
SDS. The descending arrow indicates increased SDS concentration spectrum.
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titioning will render unglycosylated molecules. Translation of
the LepTM1 and LepTM2 constructs in the presence of micro-
somes resulted in efficient glycosylation, unequivocally demon-
strating a transmembrane disposition for both TM1 and TM2
(Fig. 2, bottom panel, A and B). Control constructs with a
mutated, nonfunctional glycosylation site (QST in place of
NST; see “Materials and Methods”) were not glycosylated (data
not shown).
When both TM fragments and the native interconnecting
loop in CarMV p9 (residues 1–59) replaced the H2 segment of
Lep (construct LepTM1TM2), the level of glycosylation dropped
to 25% (Fig. 2, bottom panel, C), suggesting that the predomi-
nating topology of this construct is Nlum-Ccyt with a minor
fraction of the molecules having TM2 translocated to the lumi-
nal side. A similar level of glycosylation was also observed in a
construct where H1 of Lep was not present, i.e. when p9 was
fused directly to the P2 domain of Lep (construct p9/P2; data
not shown). The somewhat inefficient membrane-anchoring
ability of the second TM fragment of p9 correlates well with a
diminished tendency to populate the -helical conformation in
SDS when compared with the first TM fragment of p9 (Fig. 1C).
To verify that the glycosylated LepTM1TM2 molecules result
from inefficient membrane anchoring of TM2, we made an
additional construct where the hydrophobic residues Ala44-
Leu45-Ser46 located roughly in the middle of TM2 were changed
to Glu44-Glu45-Glu46 (LepTM1TM2EEE) to totally prevent
membrane insertion of this segment. As expected,
LepTM1TM2EEE was fully glycosylated (Fig. 2, bottom panel,
D).
CarMV p9 Is an Integral Membrane Protein—Once it was
demonstrated that both putative TM fragments from p9 can
insert into the ER-derived microsomal membrane using Lep as
vehicle, we sought to study the partitioning into the membrane
of the wild type p9 protein. Although MPs lack apparent ER
signal sequences and previous in vitro translated TMV MPs did
not associate with dog pancreas membranes (14), transcription/
translation products of CarMV p9 showed protein association
with heterologous microsomal membranes when analyzed by a
flotation assay (Fig. 3). CarMV p9 was quantitatively recovered
in the alkali-extracted membrane pellet, whereas only back-
ground levels were found in samples assayed in the absence of
microsomes, demonstrating proper assembly into the microso-
mal membrane. Taken together, these results (Figs. 1–3) iden-
tify p9 as a bitopic -helical integral membrane protein.
CarMV p9 Topology in the ER Membrane—The relative ori-
entation of protein membrane-spanning segments is of crucial
importance to achieve correct membrane assembly that will
allow proper function. The membrane topology predictions de-
rived from p9 are contradictory. We used four well known
topology prediction methods. All of them are designed to iden-
tify potential TM -helices and to predict the overall in-out
orientation of the protein in the membrane. Although PHD 2.1
(27) and TMHMM 2.0 (22) predict p9 with its N and C termini
in the cytoplasm, TOPPRED 2.0 (28) and HMMTOP 2.0 (29)
predict the opposite orientation, i.e. with the N and C termini
in the lumen.
To investigate the actual topology of p9, we first address the
targeting and membrane insertion capability of the first TM
fragment (TM1) by constructing a fusion where the Lep P2
domain (with a glycosylation site) was fused downstream of
TM1 (p9TM1/P2). The results shown in Fig. 4 clearly demon-
strate Ncyt-Clum orientation for this construct, in agreement
with the PHD 2.1 and TMHMM 2.0 predictions.
We next made glycosylation assays of full-length p9 followed
by alkaline extraction to study the complete topology of CarMV
p9 in the ER membrane. Although there is an endogenous
glycosylation site at Asn65-Tyr66-Ser67 in p9 (Fig. 1A), we de-
cided not to use this sequon as a topological marker, because
the distance between TM2 and the target Asn65 may be too
short to allow efficient glycosylation (24). Asn65 was mutated to
nonacceptor Gln, and a new glycosylation site was introduced
at a more favorable position (Asn69-Ser70-Ser71; construct
p9WT*). p9WT* was not glycosylated when translated in the
presence of microsomes (Fig. 5A, lane 2), in agreement with the
expected Ncyt-Ccyt topology. To show that the Asn
69-Ser70-Ser71
site can be glycosylated if translocated to the ER lumen, we
also made a construct where TM2 carried the previously
described Ala44-Leu45-Ser46/Glu44-Glu45-Glu46 mutation
FIG. 2. Top panel, membrane topology of Lep. TM segments H1 and
H2 are connected by a charged cytoplasmic loop P1. The large periplas-
mic domain P2 is translocated across the ER membrane. Engineered
sites in the coding region of Lep allow the exchange of H2 for p9
fragments and efficient glycosylation. Bottom panel, p9 putative TM
fragments insert into the microsomal membrane both individually and
as a loop-linked sequences. SDS-PAGE analysis of the Lep derived
constructs containing: TM1 (A), TM2 (B), TM1TM2 (C), and TM1TM2
carrying the A44E/L45E/S46E mutation (D) from p9. All of the con-
structs were expressed in vitro in reticulocyte lysate in the absence ()
and in the presence () of rough microsomes. Black Y-shaped symbol,
glycosylated site; gray Y-shaped symbol, unglycosylated site.
FIG. 3. SDS-PAGE analysis of alkaline extracted CarMV p9.
Lane 1, molecular markers. Lanes 2 and 3, p9 translation in the absence
and presence, respectively, of microsomal membranes.
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(p9WT*EEE) that prevents membrane integration of TM2.
Translation of this construct in the presence of microsomes
resulted in an increase in the molecular mass (Fig. 5A, lane 4)
that could be blocked by inclusion of a glycosylation inhibitor
(Fig. 5A, lane 5) and by treatment with endoglycosidase H (Fig.
5B), a glycan-removing enzyme (30). The glycosylation level
obtained for p9WT*EEE (60%; Fig. 5, A, lane 4, and B, lane 2)
is consistent with the somewhat reduced level of glycosylation
expected for a target Asn located only 15 residues upstream of
the stop codon (31). The efficient glycosylation of p9TM1/P2
and the lack of glycosylation of p9WT* unequivocally demon-
strate that the orientation of CarMV p9 is Ncyt-Ccyt.
DISCUSSION
The mechanism of cell-to-cell transport of plant viruses is
unsolved. It has been suggested that MPs may participate in
the establishment of membrane-associated replication com-
plexes, affect the intracellular distribution of plant virus, and
modify the properties of plasmodesmal pores to allow cell-to-
cell spread of infection (4, 32–34). The 30-kDa MP from TMV
has been shown to be essential for cell-to-cell spread of the
virus (35), and a topological model for this protein with two
putative -helical TM domains and a cytosolically exposed C
terminus has been proposed (10). We have previously sug-
gested that the two MPs p7 and p9 from carmoviruses provide
a simple model system to study structure/function relation-
ships of plant virus MPs (20), given their small size and sepa-
rate functions (Refs. 20 and 21 and the present work). RNA
binding properties were demonstrated for CarMV p7 (20), and
recently we used a retrostructural approach to show that the
protein is divided into three structural (and likely functional)
domains (21): a variable and unstructured N terminus, a cen-
tral helical RNA-binding domain, and a very conserved C ter-
minus that folds into a -sheet. In the present work, we dem-
onstrate that its partner CarMV p9 is an intrinsic membrane
protein with two transmembrane helices and Ncyt-Ccyt
topology.
The results obtained for TMV MP and CarMVp9 reveal a
membrane-spanning character of MPs with a likely relevant
role in the mechanism of plant virus infection. TMV MP be-
haves as an integral membrane protein because it has been
shown that treatment with salts or urea does not release its
association with ER isolated from infected cells (34). Our data
show that CarMV p9 is similarly difficult to dissociate from ER
microsomes into which it was inserted in vitro. It has been
suggested that TMV MP uses the ER for transport from the
sites of viral synthesis to plasmodesmata (14), which in fact do
contain ER, and viral infection promotes dramatic morpholog-
ical changes in ER. However, the targeting of TMV MP to ER is
not understood. Like many other plant viral MPs, it does not
contain an apparent ER signal sequence (36). Moreover, in
vitro translation experiments of TMV MP in the presence of
membranes, similar to those described in the present study,
failed to detect association with membranes (cited in Ref. 14).
In fact, it has been hypothesized that the association of TMV
MP with a host-encoded and cell wall-associated pectin methyl-
esterase may provide a location signal in trans to deliver the
MP to its site of action (37). To our knowledge, ours is the first
report that demonstrates that a plant viral MP contains in its
amino acid sequence all of the molecular information required
for its targeting and integration into a biological membrane in
the absence of additional viral or plant host proteins/compo-
nents. Furthermore, the first TM1 segment of p9 is sufficient to
drive the targeting and insertion into the ER membrane (as
deduced from the membrane insertion experiments using the
protein chimera p9TM1/P2; Fig. 4).
There is a need for topological determination and structural
characterization of MPs that will help to unravel the virus
movement mechanism(s). The actual topology of CarMV p9 in
membranes, as deduced from our experimental data using full-
length constructs, shows clearly that p9 is anchored in the
membrane through two membrane-spanning domains with its
N terminus and, chiefly, its C terminus facing the cytoplasm.
This particular topological arrangement allows the highly
FIG. 6. Comparative topological model of MPs from TMV and
CarMV. 30-kDa MP from TMV cartoon is depicted from the topological
model suggested by Brill et al. (10). CarMV MPs are outlined as deduced
from data previously reported on p7 characterization (21) and p9 topol-
ogy in the membrane from this work. -Helical domains are depicted as
rectangles, and -sheets are depicted as arrowed lines.
FIG. 4. TM1 inserts into the microsomes with Ncyt-Clum topol-
ogy. Residues 1–81 from Lep were replaced by residues 1–29 from p9
(p9TM1/P2). As before, in vitro expression was performed in reticulo-
cyte lysate either in the absence () or the presence () of rough
microsomes.
FIG. 5. Full-length p9 expression in vitro. Expressed p9 sequence
(p9WT*) differs from wild type by a double mutation N65Q/S69N. The
p9WT* sequence carrying the A44E/L45E/S46E mutation was named
p9WT*EEE. Unglycosylated and glycosylated forms are indicated by
empty and filled circles, respectively. A, lanes 1 and 3, expressed in the
absence of microsomes; lanes 2 and 4–6, expressed in the presence of
microsomes. In lanes 5 and 6, translations were made in the presence of
an acceptor peptide and in the presence of a nonacceptor peptide re-
spectively (see “Materials and Methods”). B, the p9WT*EEE construct
was translated in vitro in the absence (lane 1) and in the presence of
microsomes (lanes 2–5) and digested with 0.1 milliunit of endoglycosi-
dase H with increasing incubation times. acc., acceptor; pept., peptide.
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charged C terminus of p9 to be fully accessible toward the cell
cytoplasm.
In the absence of three-dimensional data and given the dif-
ficulty of such studies on a membrane protein, we have further
characterized CarMV p9 using a retrostructural approach
based on three synthetic peptides that cover most of the CarMV
p9 sequence. As expected, the two hydrophobic segments both
adopt an -helical conformation in a membrane-mimetic envi-
ronment, and TM1 (i.e. the “targeting” domain) has even higher
helical propensity than TM2 (Fig. 1C). The C-terminal domain
of the protein, which is highly polar (with an abundance of Ser
and Thr residues) and has a region well conserved in terms of
amino acid sequence (Fig. 1A), showed a CD spectrum indica-
tive of low secondary structure content that can be induced
to fold into a -sheet in a membrane mimetic environment
(Fig. 1D).
We have previously reported that CarMV p7 also has a
highly conserved -sheet C-terminal domain (21). Thus, these
two conserved -sheet domains could mediate protein-protein
interactions between membrane-bound p9 and its soluble part-
ner p7, either unbound or bound RNA (see our hypothetical
model in Fig. 6). It should also be noticed that in the homolo-
gous system from turnip crinkle virus, cellular fractionation
experiments have shown that turnip crinkle carmovirus p8 (the
p7 homologue) is associated with membrane structures both in
transgenic and in virus-infected plants (38), although p8 itself
does not contain either ER targeting signals or TM domains. In
the case of CarMV p7, it has been recently shown that the
amount of protein in membrane-associated fractions increases
with time after plant infection.2 In this alluring model, p7
would bind viral RNA, which would induce a conformational
change in this soluble protein, unveiling its C terminus, which
could then interact with the cytoplasm-exposed C-terminal do-
main of p9. This RNA-mediated protein-protein interaction
would confine the ternary complex to the membrane.
An inference of our model is that although multiple p7 mol-
ecules would wrap (and protect) a single viral RNA (as demon-
strated in vitro) (21), only one monomer of p9 is theoretically
required to target the complex to the membrane, and thus
lower amounts of this protein would be required. This points to
a difference with the TMV system in which the two functions
(RNA binding and membrane location) are performed by the
same protein and correlates with experimental data on the
relative amounts of p7/p9 in the cell. Although p7 and turnip
crinkle carmovirus p8 have been detected unambiguously in
infected tissue (21, 38), CarMV p9 (or any of its homologues)
has not, confirming the lower accumulation predicted by the
model. The accumulation differences also relate to the expres-
sion strategy of the two genes from a single viral subgenomic
RNA in which the p9 open reading frame is located down-
stream of p7 and far from the 5 end (17, 18).
In conclusion, the carmovirus two-MP system reproduces the
topological model previously suggested for the 30-kDa MP of
TMV (10) in which, as is the case for p9, the N and C termini
are exposed to the cytoplasm (Fig. 6). In this sense, it is impor-
tant to emphasize that carmovirus MPs are not included in the
30-kDa superfamily of viral MPs (8, 9), demonstrating similar-
ity of molecular domain organization and protein function in
the absence of detectable sequence similarity (23).
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